Vivimed Labs secures Ukraine renewed GMP nod for Jeedimetla FDF facility

Published On 2021-03-05 07:53 GMT   |   Update On 2021-03-05 07:53 GMT
Advertisement

Hyderabad: Vivimed Labs Limited, a niche Specialty Chemicals and Pharmaceuticals company has recently announced that its FDF manufacturing facility located in Jeedimetla, near Hyderabad inspected in August 2017 by the Ukraine ministry of Health, has been approved and accredited with GMP Certification effective September 2017 and same has been renewed upto 04.02.2022 on 10.02.2021.

Ukraine is a member Country of PICS, whose members include many European Countries. The GMP approval extension also includes 5 new product registrations.

Advertisement

Commenting on the Approval/renewal, Ramesh Krishnamurthy, CEO of Vivimed Labs Ltd said, "Successful renewal of PICS GMP Certification enables Vivimed to scale up its branded product distribution in CIS Countries. Export thrust is key contributor to the growth strategy of Vivimed".

Read also: Vivimed Labs gets approval for 3 ophthalmic, 3 oral liquid suspension products

Established in 1991 in Hyderabad, India, Vivimed Labs has metamorphosed from a domestic small, entrepreneurial family-operated business to a global supplier of niche molecules and formulations across Healthcare, Pharmaceuticals and Specialty Chemicals consumers in nearly 50 countries.



Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News